Abstract
Bacterial, fungal, and viral infections are frequently encountered in the oral cavity. There is no single feature characterizing infection in the mouth, and in many cases the clinical appearance may be similar to that of noninfectious conditions. Careful history taking and examination, identification of risk factors, and appropriate utilization and interpretation of diagnostic tests are critical for determining the correct diagnosis and initiating appropriate therapy. This chapter provides a rational approach to assessing, diagnosing, and managing patients with oral infections, with a special emphasis on those with underlying immunosuppression.
Access provided by CONRICYT-eBooks. Download chapter PDF
Similar content being viewed by others
Keywords
- Caries
- Cavities
- Periodontal disease
- Abscess
- Periapical abscess
- Periapical granuloma
- Periapical radiolucency
- Periodontal abscess
- Streptococcus mutans
- Ludwig angina
- Necrotizing fasciitis
- Mediastinitis
- Trismus
- Endodontic therapy
- Root canal therapy
- Neutropenia
- Calculus
- Tartar
- Plaque
- Furcation
- Pericoronitis
- Inflammatory gingival hyperplasia
- Nifedipine
- Phenytoin
- Cyclosporine
- Acute necrotizing stomatitis
- Parotitis
- Paramyxovirus
- Mumps
- Epstein-Barr virus
- Cytomegalovirus
- HIV
- Candida albicans
- Candidiasis
- Thrush
- Pseudomembranous candidiasis
- Hyperplastic candidiasis
- Erythematous candidiasis
- Angular cheilitis
- Aspergillosis
- Cryptococcosis
- Blastomycosis
- Histoplasmosis
- Paracoccidioidomycosis
- Mucormycosis
- Human papilloma virus
- Enterovirus
- Shingles
- Postherpetic neuralgia
- Ramsay Hunt syndrome
- Herpes zoster oticus
- Mononucleosis
- Oral hairy leukoplakia
- Posttransplant lymphoproliferative disease
- Squamous cell carcinoma
- Squamous papilloma
- Verruca vulgaris
- Condyloma acuminatum
- Focal epithelial hyperplasia
- Heck disease
- Coxsackievirus
- Herpangina
- Hand-foot-and-mouth disease
Introduction
Bacterial, fungal, and viral infections are frequently encountered in the oral cavity. The immune system, protective components in saliva, and mucosal integrity are all key elements that work in concert to prevent the development of infection. When any of these are compromised, the resulting imbalance increases the potential for commensal, latent, or invading organisms to cause disease. Behavioral factors, including diet, nutrition, hydration, and oral hygiene, also have a significant influence on an individual’s risk. Medications play an important role: immunosuppressive and immunomodulatory agents alter immune function, broad spectrum antibiotics affect the ecological balance of the oral flora, and xerogenic agents impact on the composition and flow of saliva.
There is no single feature characterizing infection in the mouth; findings range from painful swelling to mucosal ulceration to painless papules. The clinical appearance may be similar to that of noninfectious conditions. Therefore, careful history taking and examination, identification of risk factors, and appropriate utilization and interpretation of diagnostic tests (see Chap.3) are critical. The clinical presentation of some infections may be altered in the immunocompromised patient: the anatomic distribution of lesions can be quite different, typical signs of infection may be diminished or absent, and standard doses of therapeutic medications may be ineffective. Failure to diagnose and initiate appropriate therapy in these patients can result in needless pain and suffering as well as progression to systemic infection.
Bacterial Infections
Oral bacterial infections are most commonly of dental origin and can progress to abscess formation with potentially significant complications if left untreated. In an otherwise healthy individual, it is exceedingly rare for a nonodontogenic bacterial infection to develop within the oral cavity. Infection rarely occurs following oral surgical procedures (such as tooth extraction and soft tissue biopsy) or minor trauma. Infection of the salivary gla nds is uncommon and mucosal infection outside of the periodontium (e.g., other than gingivitis and periodontitis) is generally only encountered in those who are immunosuppressed.
Odontogenic Infections
Odontogenic infections can be broadly classified as either endodontal, which are characterized by infection of the dental pulp initiated by dental caries; or periodontal, which are characterized by infection of the tooth’s supporting structures initiated by accumulation of plaque and calculus (Fig. 7.1). In both cases, the primary risk factors include inadequate oral hygiene with dental plaque accumulation. While the reasons are not entirely clear, many patients with high caries rates often have minimal periodontal disease, whereas patients with advanced periodontal disease often have few caries.
Dental Caries
Caries are caused by the metabolism of sugar in dental plaque by Streptococcus mutans, resulting in the production of acid and subsequent demineralization of the protective enamel layer. The destructive process advances inward toward the pulp, and in the absence of treatment, results in pulpal necrosis and potential abscess formation (Fig. 7.2). Infected material drains from the pulp chamber through the apical foramen into surrounding bone, causing abscess formation at the root apex (periapical abscess; Fig. 7.3). From there infection can spread to other parts of the oral cavity, face, or neck and lead to potentially life-threatening soft tissue infections such as Ludwig angina, deep neck abscess, necrotizing fasciitis, and mediastinitis (Figs. 7.4, 7.5, and 7.6). Infection in molars can result in trismus (limitation of mouth opening) due to inflammation of the adjacent masticatory muscles (Fig. 7.7).
Decay can form on any tooth surface, but frequently affects the occlusal surfaces of posterior teeth due to the presence of anatomic pits and fissures. The interproximal surfaces are also commonly affected because plaque can be difficult to remove from these areas. The facial surfaces near the gingival margin and exposed root surfaces are particularly susceptible because they are covered with cementum, which is much softer than enamel. Early lesions may show areas of decalcification on the enamel, and are characterized by white spots that may collapse under the pressure of a dental instrument (Fig. 7.8). More advanced lesions demonstrate obvious cavitation with brownish-black discoloration (Figs. 7.9 and 7.10). Entire sections of the tooth may fracture and exposure of the pulp chamber may be evident (Fig. 7.11).
Intraoral dental radiographs are used to diagnose caries, which appear as distinct areas of radiolucency within the tooth structure (Fig. 7.12). These can also demonstrate the presence of a periapical radiolucency , indicative of pulpal pathology (Figs. 7.4, 7.5, and 7.6). Computed tomography (CT) may be indicated if extensive soft tissue swelling is present and there is concern for progression of infection into the deep spaces of the neck (Fig. 7.13). When dental infection is suspected, the patient should be referred to a dentist or other oral health care specialist for further evaluation.
As long as the pulp chamber has not been breached, caries can be mechanically removed and the tooth can be restored with a variety of dental materials. With pulpal involvement, endodontic therapy (root canal therapy) or extraction of the tooth is required. Endodontic treatment involves removal of neurovascular tissue from the pulp chamber and replacement with an inert material such as gutta-percha. In cases of localized intraoral swelling, incision and drainage may also be necessary in conjunction with definitive treatment of the tooth.
The only significant medical risk factor for the development of dental caries is reduced salivary function (see Chap. 8). In patients with profound neutropenia, previously latent or subclinical periapical infections can become acutely active with soft tissue swelling or localized gingival and mucosal necrosis (Fig. 7.14). Antibiotics should be given in these situations, as well as in cases of significant soft tissue swelling. Otherwise, the decision to prescribe antibiotics will depend on the individual clinical situation.
The mainstays of caries prevention involve attention to diet, maintenance of oral hygiene, and use of fluoride. Overall consumption of carbohydrate and frequency of exposure are both important. For example, an individual who ingests snacks or sugary beverages frequently throughout the day is at higher risk for caries than someone who eats only three meals per day and drinks water. Brushing with a soft toothbrush and fluoride toothpaste for 2 min at least twice daily (ideally after every meal) removes dental plaque accumulation and significantly reduces the risk of dental caries. Daily use of dental floss removes plaque from the interproximal regions, which are otherwise difficult areas to clean. Systemic fluoride, usually obtained through fluoridated water, is important during tooth development in children because it incorporates into the developing tooth structure and renders it less susceptible to attack from caries. Prescription topical fluoride preparations are typically reserved for individuals considered to be at high risk for caries.
Periodontal Disease
Periodontal disease is caused by the accumulation of plaque and calculus (calcified dental plaque also referred to as tartar), that leads to chronic inflammation of the adjacent gingiva, periodontal attachment structures, and alveolar bone. Periodontal “pockets” form between the tooth and gingival soft tissues as the infected material migrates apically. As the pockets become deeper and more inflamed, it becomes more difficult to adequately clean these areas. Heavy smoking also contributes to inflammation of the periodontium. Signs of periodontal disease include plaque and calculus accumulation, gingival recession or bleeding, periodontal pocketing, root exposure, and tooth mobility (Figs. 7.15, 7.16, and 7.17). Advanced periodontal disease is often associated with foul smelling breath (halitosis).
The periodontium can become acutely infected with abscess formation and swelling of the adjacent gingiva (Fig. 7.18). This is more likely to develop in areas with deep periodontal pockets and furcation involvement (exposure of the space between the roots of multirooted teeth). Pericoronitis is a condition in which the gingiva surrounding the crowns of partially erupted molars (usually the third molar or “wisdom tooth”) becomes painfully inflamed (Fig. 7.19).
Radiographic features of periodontal disease include the presence of calculus both above (supragingival) and below (subgingival) the gingival margin, as well as loss of alveolar bone surrounding the teeth (Fig. 7.20). Generalized horizontal bone loss in all four quadrants signifies longstanding inflammation. Localized areas of vertical bony defects represent areas of advanced bone loss and are often associated with tooth mobility and an increased risk for abscess formation.
Primary management of periodontal disease includes professional scaling and root planning, with removal of calculus and inflammatory tissue from around the teeth and along root surfaces in conjunction with attention to improved oral hygiene. In more advanced cases, surgical procedures may be indicated to reduce pocket depth. Antimicrobial therapies include topical rinses, such as chlorhexidine gluconate; locally delivered antibiotics, such as minocycline injected subgingivally; and systemic antibiotics.
Inflammatory Gingival Hyperplasia
Although uncommon, the gingiva can become markedly enlarged in response to localized inflammation. This can be observed in the context of periodontal disease or in response to certain medications. Associated medications include calcium channel blockers (such as nifedipine), calcineurin inhibitors (cyclosporine), and anticonvulsants (phenytoin). In all cases, poor oral hygiene is believed to be a significant contributing factor. The underlying mechanism is thought to be related to calcium regulation of collagen degradation in fibroblasts resulting in increased production of dense connective tissue. Unlike the gingival enlargement that can be seen with leukemic infiltration (see Chap. 11), these lesions are generally firm and of a normal pink color without significant associated bleeding (Figs. 7.21, 7.22, and 7.23). Treatment includes gross debridement of plaque and calculus, which often results in partial or complete resolution. If associated with a medication, discontinuation or substitution is indicated and often effective in reducing progression of gingival enlargement. If this does not result in significant improvement, gingivectomy, usually performed by a periodontist, is indicated.
Acute Necrotizing Stomatitis
Previously referred to as “trench mouth” described in soldiers fighting on the front lines in World War I, acute necrotizing stomatitis is seen mainly in patients with severe malnutrition and very poor oral hygiene. It has also been observed disproportionately in patients with HIV disease. This aggressive and painful periodontal infection is caused by the convergence of poor oral hygiene, immune suppression, and inadequate nutrition. When localized to the gingiva, the condition is called acute necrotizing gingivitis; if it progresses to involve the periodontium, it is referred to as acute necrotizing periodontitis. Rarely, this develops into a destructive and devastating infection of the hard and soft orofacial tissues resulting in a disfiguring condition termed noma, which is seen almost exclusively in developing countries.
Clinical features of necrotizing stomatitis include severe gingival inflammation with edema, bleeding, blunting of tissue contours, and “punched out” appearing interdental defects with varying areas of ulceration (Fig. 7.24). Necrotic alveolar bone may be evident, and heavy plaque and calculus accumulations are generally present. Intraoral radiographs demonstrate advanced bone loss with vertical defects that often correspond to areas of extensive soft tissue destruction. This condition is associated with a very foul odor, reflective of the extent of infection and tissue necrosis.
Treatment includes aggressive debridement and administration of antibiotics. Due to the extent and depth of infection, local anesthesia is often required for adequate removal of all plaque and calculus deposits. In addition, daily rinses with chlorhexidine gluconate provide a topical effect, and this medication is continued indefinitely after systemic antibiotics are completed. Following initial therapy, home oral care maintenance is critical to prevent recurrence. Underlying factors such as poor nutrition and immunosuppression must also be addressed.
Parotitis
Bacterial parotitis is characterized by painful acute swelling of the parotid gland, commonly on one side (Fig. 7.25). Risk factors include dehydration, salivary gland hypofunction, and sialolithiasis. In the setting of diminished salivary outflow, commensal bacteria ascend the duct in a retrograde fashion resulting in infection within the parenchyma of the gland. It is usually caused by Staphylococcus aureus . Extraoral examination demonstrates visible fullness of the gland, often with erythema of the overlying skin and outward displacement of the ear. Palpation of the gland elicits discomfort, and intraoral examination may show swelling and erythema in the region of the duct orifice. Purulent discharge may be visible as well. Bacterial infections also affect the submandibular gland in a similar fashion.
Treatment includes broad spectrum systemic antibiotics, hydration to enhance salivary flow, and pain management. Drainage of the gland can be enhanced by “milking” it with gentle but steady pressure applied extraorally, which generally also improves pain. Use of sialogogues, such as sour lemon, stimulates salivary flow and helps flush out the gland. Purulent discharge should be collected for aerobic and anaerobic bacterial cultures, especially if the patient has already been treated with antibiotics without clinical improvement. Salivary stones (see Chap. 8), when present, should be removed if possible to prevent recurrence (Fig. 7.25c).
Viral salivary gland infections are characterized by nonsuppurative swelling that may or may not be painful and are usually bilateral. Mumps is the most common cause of viral parotitis, mediated by paramyxovirus . Given the widespread use of the MMR (measles/mumps/rubella) vaccine, this condition is encountered infrequently in most developed countries. Other viruses known to infect the salivary glands are cytomegalovirus (CMV), Epstein-Barr virus (EBV), and HIV.
Fungal Infections
The vast majority of oral fungal infections are caused by Candida albicans , which is considered a component of the normal oral flora. Deep fungal infections are in comparison exceedingly rare and are generally only encountered in immunocompromised individuals; these will only be discussed briefly.
Oral Candidiasis
As candida species make up part of the c ommensal oral flora in most individuals, it is a change in the normal oral environment rather than actual exposure o r “infection” per se, that results in clinical infection (candidiasis or thrush). This can be precipitated by reduced salivary flow (see Chap. 8), immunosuppression (including poorly controlled diabetes mellitus), and use of antibiotics or steroid medications. Oral candidiasis can be encountered in any age group; organisms colonize the mucosa resulting in a superficial infection that typically causes symptoms of soreness and burning. It is not uncommon for patients to also describe discomfort in the throat with swallowing, indicating the presence of oropharyngeal or esophageal involvement.
The most common clinical presentation is generalized patchy white to yellow spots or plaques that have a “cottage cheese” like appearance, referred to as pseudomembranous candidiasis (Figs. 7.26, 7.27, and 7.28). These can be easily wiped away with gauze leaving an erythematous base with minimal bleeding. Lesions can be seen anywhere but are frequently located on the tongue, buccal mucosa, and palate. Much less frequently, candidiasis can present with a purely erythematous macular lesion, and is termed erythematous candidiasis (Fig. 7.29). Very rarely, candidiasis can present as a white plaque that does not rub away and looks clinically identical to leukoplakia (see Chap. 9); this is referred to as hyperplastic candidiasis. The presence of oral lesions is frequently associated with infection of the corners of the mouth, resulting in painful erythematous raw and cracked skin known as angular cheilitis . This is seen more frequently in edentulous patients with overclosure (collapse of jaws) and in individuals with a lip licking habit (Fig. 7.30).
Diagnosis of candidiasis can typically be made by clinical features alone. As the hyperplastic form cannot be distinguished clinically from leukoplakia, an incisional biopsy is required for diagnosis. Fungal culture should be reserved for lesions that are not responsive to empiric therapy. In such cases, sensitivity testing should also be requested. Clinical response to empirical antifungal therapy, with complete resolution of signs and symptoms, confirms the diagnosis.
Primary management of oral candidiasis is with topical and systemic antifungal agents (Table 7.1). The most commonly utilized topical agents include nystatin suspension and clotrimazole troches. While both can be effective, there is greater evidence to support the use of clotrimazole troches, although some cases may not respond even with adequate dosing. Systemic therapy using fluconazole is usually highly effective. If applicable, removable dentures should also be treated, as these are frequently colonized and will continue to reinfect the underlying soft tissue. Preparations for denture disinfection are commercially available; however, a simple and inexpensive alternative is to soak the prosthesis (if it does not contain metal) overnight in a 1:10 dilution of household bleach. Angular cheilitis is effectively managed with topical nystatin/triamcinolone cream.
Management of any underlying contributing factors is important in preventing recurrence. Long-term prophylaxis should be prescribed in cases of chronic recurrent disease. Topical agents may be effective; however, systemic treatment is often easier for the patient to manage due to more convenient dosing schedules. In most cases, fluconazole given once or twice weekly is highly effective at preventing recurrent infection.
Deep Fungal Infections
Non-candidal oral fungal infections are rare and are seen almost exclusively in immunosuppressed individuals. Infections include aspergillosis, cryptococcosis, blastomycosis, histoplasmosis, paracoccidioidomycosis, and mucormycosis. Lesions typically present as deep necrotic ulcerations that can lead to localized destruction and tissue invasion as well as systemic dissemination (Fig. 7.31). Oral lesions are often accompanied by lesions within the respiratory tract, such as the lungs or sinuses, and diagnosis requires biopsy. Imaging studies should be ordered to evaluate the extent of underlying tissue involvement. Management includes aggressive systemic antifungal therapy in conjunction with surgical debridement. Despite aggressive therapy, these infections are associated with high rates of morbidity and mortality.
Viral Infections
A wide variety of viral infections affect the oral cavity (Table 7.2). These i nclude members of the human herpes virus family (herpes simplex 1&2, varicella zoster virus [VZV], CMV, and EBV), human papillomaviruses, and enteroviruses. Some infections are common in normal health, while others are seen only in immunocompromised individuals. Clinical appearances are often very similar to noninfectious oral conditions and certain infections may present quite differently between the immunocompetent versus immunocompromised state s. Accurate and prompt diagnosis is necessary, as the choice of appropriate management will depend on the specific organism involved, and can vary from palliative treatment alone to antiviral therapy or surgery.
Herpes Simplex Virus
Herpes simplex virus (HSV ) is a ubiquitous virus to which the majority of humans are exposed at some point during their lifetime, usually by the teenage years but occasionally later in adulthood. The virus is transmitted through saliva by direct contact, and becomes latent in the trigeminal nerve ganglion following primary infection. Once present, the virus remains dormant and has the potential to reactivate throughout the lifetime of the individual. Subclinical viral shedding in the saliva is common even in the absence of clinically evident lesions, likely explaining to some extent the widespread prevalence of this infection in the human population. Although HSV-1 was historically considered specific to the oral cavity and HSV-2 was considered specific to the anogenital region, either subtype can cause oral infections. Other than minor molecular differences between HSV-1 and HSV-2 strains, the resultant infection, natural course of disease, and treatment are exactly the same.
Primary HSV is characterized by flu-like symptoms that typically precede onset of oral lesions by 2–3 days and severe oral ulcerations that can affect both the keratinized and nonkeratinized mucosa (Fig. 7.32). The gingiva is typically very painful and fiery red in appearance. Ulcerative lesions begin as small vesicles that often develop in clusters and eventually break down to form coalescing, shallow, irregularly shaped ulcerations. The pain associated with these lesions is severe. In the absence of antiviral therapy, the clinical course of primary HSV is typically no more than 14 days with complete resolution of all signs and symptoms. There is a wide range of clinical presentations, however, and many primary infections are probably never diagnosed. A history of intimate physical contact within 1 week of developing signs and symptoms of primary HSV infection should be sought.
Diagnosis can often be made by history and clinical examination alone, and treatment should be initiated immediately. Viral culture, PCR or direct fluorescent antibody (DFA) testing of ulcerative lesions can confirm the diagnosis. Positive serology for HSV IgM antibodies signifies primary infection, but the presence of IgG antibodies can only confirm prior exposure. Although primary HSV is a self-limiting infection, early treatment with antiviral medication can reduce the severity and length of illness but will not prevent the establishment of latency. Most important is symptomatic and supportive care, as oral intake can be severely limited during primary infection due to pain. Use of systemic and topical analgesics in conjunction with hydration and nutritional support are critical aspects of management, especially in young children. Management of primary and secondary HSV infection is summarized in Table 7.2.
Once infected, the virus becomes latent in the trigeminal ganglion with the potential for reactivation or recrudescence. Well-known triggers include stress, hormonal changes, sun exposure, and trauma. Lesions are typically preceded by a prodrome, which is characterized by tingling, itching, or a painful sensation in the area where the lesion will appear. The majority of secondary lesions occur on and around the lips and nostrils and present initially with multiple small vesicles that break down and form a painful, crusted, ulceration (Fig. 7.33). Much less frequently, lesions develop intraorally, where they are limited to the keratinized mucosa. Intraoral lesions look identical to those of primary infection but are generally unilateral and limited to one specific anatomic site (e.g., tongue, gingiva, lip, and hard palate). In immunocompromised patients lesions may develop extraorally as well as intraorally, and lesions can be much more extensive; multiple areas may be affected, including both the keratinized and nonkeratinized mucosa (Fig. 7.34). Patients are highly infectious during the period of active lesions; however, viral shedding can occur at any time regardless of the presence of lesions.
While the diagnosis of recrudescent HSV infection can be made by viral culture, this is rarely necessary except for atypical cases. Treatment at the initial onset of prodromal symptoms can effectively suppress vesicle formation or reduce the severity and length of the outbreak. Topical antiviral therapy can be effective if applied frequently throughout the day, but systemic therapy is generally preferable due to better compliance and efficacy.
Antiviral therapy is of limited utility following appearance of vesicles; lesions will heal completely within 7–10 days. For those with frequent recurrent herpes labialis, prophylactic suppressive antiviral therapy is safe and effective.
Varicella Zoster Virus
Primary infection with VZV results in chicken pox, following which the virus becomes latent in the spinal dorsal root ganglia. While reactivation (herpes zoster; “shingles”) can develop at any time, this occurs at a much higher frequency in adults over 60 years of age, and is thought to be related to immunosenescence to VZV. With the introduction of the VZV vaccine, the epidemiology of herpes zoster infection appears to be changing; the frequency of primary infection in children is reduced; and vaccination of older adults results in a lower risk of reactivation. A rare but significant complication of herpes zoster infection is postherpetic neuralgia (PHN) , which is characterized by burning neuropathic pain in the area of previous lesions.
Similar to recrudescent HSV infection, herpes zoster lesions are preceded by a prodrome, typically characterized by a tingling or stabbing sensation. The trigeminal nerve is involved in approximately 20 % of cases and most commonly affects the ophthalmic division (V1). Lesions are characteristically unilateral and appear identical clinically to those of HSV (Fig. 7.35). The distribution of lesions follows the dermatome of the affected nerve. Diagnosis is generally made on clinical findings alone, although viral culture and DFA testing can provide confirmation. When the second or third divisions of the trigeminal nerve are affected (V2, V3), lesions may present both extraorally and intraorally. Prior to the appearance of vesicles and ulcers, intraoral herpes zoster may initially present with severe pain that can easily be confused with odontogenic infection, sinusitis, or myofascial pain dysfunction. When cranial nerves VII and VIII are involved, facial nerve paralysis and hearing loss can occur (known as Ramsay Hunt syndrome or herpes zoster oticus). In immunocompromised patients, multiple dermatomes may be affected, lesions may present bilaterally, and disseminated zoster can develop resulting in visceral pain, organ involvement, and death.
Antiviral therapy with acyclovir, valacyclovir, or famciclovir for 7–10 days within 48–72 h following appearance of lesions can be effective in reducing pain, promoting healing, and preventing or reducing the severity of PHN. While combined treatment of antiviral medication with high-dose corticosteroids has been evaluated to reduce the risk of developing PHN, its efficacy and clinical utility remain controversial. PHN can be managed with topical and systemic agents similar to other neuropathic pain conditions (see Chap. 10).
Cytomegalovirus
Most individuals are infected with CMV at some point during their lifetime. Initial infection is usually asymptomatic but may present as a mild flu-like illness or mononucleosis-like syndrome that is clinically identical to that caused by EBV (see below). The salivary glands become infected and provide a source of constant viral shedding. Clinically significant disease, such as pneumonia, gastroenteritis, and retinitis, due to reactivation only occurs in immunocompromised individuals. Blood tests used to evaluate CMV disease activity include antibody testing, antigen testing, shell vial assay, and qualitative and quantitative PCR. Results from these tests may support a diagnosis, or be used as an indication to begin antiviral therapy in immunocompromised patients; however, no specific findings define infection.
Nonspecific painful oral ulcerations resembling major aphthous (see Chap. 5) may develop in immunocompromised patients, and CMV involvement can only be diagnosed by biopsy (Fig. 7.36). Histopathology demonstrates enlarged cells within the vascular endothelial cells in the connective tissue with intranuclear inclusions that have a classic “owl’s eye” appearance; immunohistochemistry and in situ hybridization for CMV antigens are both useful tests for confirmation of the diagnosis. Treatment with ganciclovir and valganciclovir are both highly effective in managing CMV disease.
Epstein-Barr Virus
Similar to CMV, most humans are exposed to EBV . Primary infection (acute infectious mononucleosis) is most commonly seen in adolescents and young adults; when symptomatic, it is characterized by sore throat, fever, and lymphadenopathy. Diagnosis includes (a) lymphocytosis, (b) atypical lymphocytes on peripheral smear, and (c) positive EBV serology. The salivary glands and oropharyngeal lymphoid tissues become infected and are responsible for constant shedding in saliva during latency, which is most commonly responsible for viral transmission.
B lymphocytes are also an important site of infection and latency. EBV is associated with endemic Burkitt lymphoma, nasopharyngeal carcinoma, and non-Hodgkin lymphoma, including posttransplant lymphoproliferative disease. The only oral condition that is specifically attributed to EBV is oral hairy leukoplakia (OHL) , a benign condition characterized by painless white plaques on the ventrolateral tongue (see Chaps. 4 and 11). OHL is only seen in immunosuppressed individuals and has primarily been reported in association with HIV disease. Biopsy shows classic EBV-associated viral cytopathic changes in the superficial epithelium characterized by nuclear clearing and peripheral margination of chromatin (nuclear beading) caused by EBV viral replication. In situ hybridization can further confirm the presence of EBV in the tissue. Once diagnosed, specific treatment is not necessary; however, antiviral therapy with acyclovir can be effective for clinical resolution of lesions. This should not be confused with leukoplakia, which is not EBV associated and is considered a potentially malignant lesion (see Chap. 9).
Human Papilloma Virus
Human papilloma virus (HPV ) is a ubiquitous virus with over 100 identified subtypes. It is associated with both benign and malignant epithelial growths of the aerodigestive and anogenital mucosa. Transmission is by direct contact and prevalence in the population is estimated to be at least 50 %. The most common subtypes associated with benign mucosal proliferative lesions are 2, 4, 6, 11, 13, and 32. Subtypes 16 and 18 have been associated with oropharyngeal squamous cell carcinoma as well as cancer of the cervix (see Chap. 9). HPV vaccine is now available for both women and men and is considered protective against cervical cancer, anogenital warts, and anal cancer. It has not been evaluated with respect to prevention of oropharyngeal carcinoma. The association of various sexual behaviors with primary infection, mechanisms of latency, and risk factors for the development of oral lesions are unclear.
Oral lesions caused by HPV infection include squamous papilloma, verruca vulgaris, condyloma acuminatum, and focal epithelial hyperplasia (or Heck disease; Figs. 7.37, 7.38, 7.39, and 7.40). While differences exist clinically between these lesions, they are all characterized by well-defined epithelial proliferations that are pink to white in color, ranging from 1.0 mm to 1.0 cm in diameter, often with a pebbly or “wart-like” surface. Lesions, although painless, may be subject to trauma from the dentition, can be annoying, and may have cosmetic consequences when located on the lips or tongue. In immunocompromised patients, in particular those with HIV infection, multiple lesions may occur resulting in a condition called papillomatosis (Fig. 7.41). None of these benign lesions are considered to have any malignant potential.
Diagnosis is primarily based on clinical appearance; however, lesions may need to be biopsied to rule out dysplasia or malignancy, especially in patients who are at increased risk for oral cancer. Lesions are characterized histopathologically by marked epithelial hyperplasia and koilocytosis. Management of solitary lesions is by simple surgical excision. Treatment of multiple lesions can be more challenging and approaches include surgery, cryotherapy, laser ablation, and intralesional interferon alpha therapy; unfortunately recurrence is common in these cases. Lesions on the lip and vermillion border (but not intraoral mucosa) may be treated with topical immunomodulatory (imiquimod) or antineoplastic (5-fluorouracil) agents, although results are variable.
Enterovirus
Enteroviruses belong to the Picornaviridae (small RNA virus) family of viruses and include, among many others, coxsackievirus. Herpangina and hand-foot-and-mouth disease are mediated by coxsackievirus and are both characterized by painful oropharyngeal ulcers (Fig. 7.42). Enteroviruses are transmitted primarily by the fecal–oral route, but may be transmitted by aerosolized saliva droplets as well during the acute phase of infection. Outbreaks tend to occur during the summer and fall, but in temperate climates can occur year round. Regular hand washing is the most effective preventive measure. The incubation period is 3–7 days, followed by acute onset of variable flu-like symptoms (sore throat, dysphagia, fever, and malaise), although in many cases infection is entirely subclinical. While more common in children, enterovirus infection can present at any time during life.
Herpangina is characterized by multiple small vesicles on the soft palate and tonsillar pillars that rapidly break down to form aphthous-like ulcers. Oral lesions may be more widespread in hand-foot-and-mouth disease and are accompanied by cutaneous vesicles. The infection is self-limiting, with systemic symptoms typically resolving within several days and oral lesions healing within 7–10 days. In most cases diagnosis is made by clinical findings alone, although various tests are available for atypical cases or for epidemiological purposes (e.g., culture, serology, and PCR). There is no specific antiviral therapy for enterovirus infection; supportive care including pain management, hydration, and soft diet should be provided until lesions and symptoms resolve.
Sources
Arduino PG, Porter SR. Herpes simplex virus type 1 infection: overview on relevant clinico-pathological features. J Oral Pathol Med. 2008;37:107–21.
Enwonwu CO, Falkler WA, Idigbe EO. Oro-facial gangrene (noma/cancrum oris): pathogenetic mechanisms. Crit Rev Oral Biol Med. 2000;11:159–71.
Gnann JW, Whitley RJ. Herpes zoster. N Engl J Med. 2002;347:340–6.
Horning GM. Necrotizing gingivostomatitis: NUG to noma. Compend Contin Educ Dent. 1996;17:951–4.
Hosseini SM, Borghei P. Rhinocerebral mucormycosis: pathways of spread. Eur Arch Otorhinolaryngol. 2005;262:932–8.
Lerman M, Laudenbach J, Marty F, et al. Management of oral infections in cancer patients. Dent Clin N Am. 2008;52:129–53.
Nahlieli O, Bar T, Shacham R, et al. Management of chronic recurrent parotitis: current therapy. J Oral Maxillofac Surg. 2004;62:1150–5.
Sitheeque MA, Samaranayake LP. Chronic hyperplastic candidosis/candidiasis (candidal leukoplakia). Crit Rev Oral Biol Med. 2003;14:253–67.
Sweeney CJ, Gilden DH. Ramsay Hunt syndrome. J Neurol Neurosurg Psychiatry. 2001;71:149–54.
Woo SB, Challacombe SJ. Management of recurrent oral herpes simplex infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:S12e1–8.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bruch, J.M., Treister, N.S. (2017). Oral Infections. In: Clinical Oral Medicine and Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-29767-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-29767-5_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-29765-1
Online ISBN: 978-3-319-29767-5
eBook Packages: MedicineMedicine (R0)